Efficacy and Safety of Dual Blockade of the Renin–Angiotensin–Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis-Reference-Cited by-同舟云学术

Efficacy and Safety of Dual Blockade of the Renin–Angiotensin–Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis

Published:2019-02-09 Issue:3 Volume:19 Page:259-286
ISSN:1175-3277
Container-title:American Journal of Cardiovascular Drugs
language:en
Short-container-title:Am J Cardiovasc Drugs

Author:

Feng Yanhuan,Huang Rongshuang,Kavanagh Janet,Li Lingzhi,Zeng Xiaoxi,Li Yi,Fu Ping^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/article/10.1007/s40256-018-00321-5/fulltext.html

Reference77 articles.

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14.

2. Shrishrimal K, Hart P, Michota F. Managing diabetes in hemodialysis patients: observations and recommendations. Cleve Clin J Med. 2009;76:649–55.

3. National Institute of Diabetes and Digestive and Kidney Diseases. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. https://www.usrds.org/2009/pdf/V1_06_09.pdf . Accessed 7 Feb 2019.

4. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45:S1–153.

5. ESH/ESC Task Force for the Management of Arterial Hypertension. Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;2013(31):1925–38.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of transplant benefits with the U.S. Scientific Registry of Transplant Recipients by semiparametric regression of mean residual life;The Annals of Applied Statistics;2024-09-01

2. Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone;Journal of Diabetes and its Complications;2024-05

3. The therapeutic effect of mesenchymal stem cells in diabetic kidney disease;Journal of Molecular Medicine;2024-02-29

4. Pharmacological Management of CKD;Principles of Specialty Nursing;2024

5. The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis;Nephrology Dialysis Transplantation;2023-06-12